GENEVA, Aug. 7 -- PENTIXAPHARM AG filed a patent application (EP2024/081904) for “ANTIBODIES AGAINST CD44”. With publication no. WO/2025/099324, here are the other details related to the patent application:
Kind: Correction of entry in Section I of the PCT Gazette [A8]
IPC: C07K 16/28
Notably, the patent application was submitted under the International Patent Classification (IPC) system, which is managed by the World Intellectual Property Organization (WIPO).
Disclaimer: Curated by HT Syndication....